Large bore peripheral IV cannulae
The segment on large bore peripheral cannulae in the Peripheral intravenous access page has been merged with the segment on RIC lines in the Peripheral venous cannula insertion page.
Dunn RJ
The segment on large bore peripheral cannulae in the Peripheral intravenous access page has been merged with the segment on RIC lines in the Peripheral venous cannula insertion page.
The Peripheral venous access page has been updated with a revised section on substances best avoided being given through a peripheral venous line.
The Intraosseous access page has had a minor reorganisation and update.
A new page called US guided peripheral venous access has been created from the contents of the Difficult IV access page.
The Stroke prevention in atrial fibrillation page has had a number of other updates.
The Stroke prevention in atrial fibrillation page has been updated with additional information about LAA occlusion.
The Assessment of atrial fibrillation/flutter page has been updated with additional information about device detected AF.
The Stroke prevention in atrial fibrillation page has been updated with additional information about the limitations of the CHA2DS2VA score.
The table on the Stroke prevention in atrial fibrillation page previously demonstrating the CHA2DS2Vasc score and stroke risk has been updated to demonstrate the CHADS2VA score and stroke risk.
The Stroke prevention in atrial fibrillation page has been updated with a revised segment on AF stroke risk.
The Oxygen therapy page has been updated with expanded details on the minimum O2 flow rate through a Hudson face mask.
All instances of PO2 and PCO2 in the manual have been updated to PaO2 and PaCO2 whenever relevant to prevent readers thinking that PO2 and PCO2 may mean venous PO2 or PCO2.
The Endotracheal extubation page has been updated with additional emphasis on ensuring the extent of neuromuscular paralysis is measured and reversed prior to extubation. In particular, do not assume neuromuscular blockade will have worn off after a few hours in ED patients.
The Non depolarising neuromuscular blocking agents page has been updated with additional information about the duration of action of rocuronium, particularly emphasising it is highly variable and may be very significantly prolonged.
The Assessment of atrial fibrillation or flutter page has been updated with information about the beat to beat variation in QRS amplitude in AF,
The Supraventricular tachycardia page has been updated to better reflect the dangers of AV nodal blockade in AF through an accessory pathway.
The Supraventricular tachycardia page has been updated with additional information about the features of AF through an accessory pathway.
The Supraventricular tachycardia page has had a significant correction. Previously it was stated that in AFib with an accessory pathway the ventricular rate was often < 200bpm, when it is actually commonly > 200bpm.
The Permanent transvenous pacemakers page has been updated with additional information about lead positions.
The Permanent transvenous pacemakers page has been updated with a diagram of a typical 2 lead His bundle pacemaker configuration.